POU2F1 and cancer: Overexpression of Oct-1 correlates with tumor aggressiveness in cancers of the breast, esophagus, stomach, prostate, lung, head and neck, cervix, colorectal cancer, diffuse large B-cell lymphoma, and other malignant tumors [1, 8].